Pure Nutriplant Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 06-07-2024
- Paid Up Capital ₹ 0.11 M
as on 06-07-2024
- Company Age 42 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 28.78%
(FY 2022)
- Profit 47.72%
(FY 2022)
- Ebitda 205.69%
(FY 2022)
- Net Worth 16.42%
(FY 2022)
- Total Assets 13.33%
(FY 2022)
About Pure Nutriplant Chemicals
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Pravin Warke, Vishal Warke, and Vishnu Warke serve as directors at the Company.
- CIN/LLPIN
U24110MH1982PTC026881
- Company No.
026881
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 1982
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pure Nutriplant Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Warke  | Director | 10-Sep-1991 | Current |
| Pravin Warke | Director | 10-Sep-1991 | Current |
| Vishnu Warke | Director | 08-Apr-1982 | Current |
Financial Performance and Corporate Structure Insights of Pure Nutriplant Chemicals.
Pure Nutriplant Chemicals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 28.78% increase. The company also saw a substantial improvement in profitability, with a 47.72% increase in profit. The company's net worth Soared by an impressive increase of 16.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pure Nutriplant Chemicals?
In 2020, Pure Nutriplant Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Himedia Laboratories Private LimitedActive 42 years 3 monthsPravin Warke, Vishal Warke and 1 more are mutual person
Warkem Biotech Private LimitedActive 19 years 11 monthsPravin Warke, Vishal Warke and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pure Nutriplant Chemicals?
Unlock and access historical data on people associated with Pure Nutriplant Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pure Nutriplant Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pure Nutriplant Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
